written on 10.04.2014
Tags:
,

20 Promising Drugs to Watch in 2014

TAGS: ,

Peter Robins writes for Outsourced Pharma on promising drugs changing clinical phase or receiving approval. Numerous drug therapies changed clinical phase, received approval, and launched in the final quarter of 2013, creating an exciting landscape for drugs to watch in 2014. Whether it’s tracking a new HIV drug gaining approval or the advancement of a […]

Latest Report